The role of heparin-associated antiplatelet antibodies in the outcome of arterial reconstruction (Q33328706)

25 July 2017

title

The role of heparin-associated antiplatelet antibodies in the outcome of arterial reconstruction (English)

1 reference

25 July 2017

1 reference

Calaitges JG

1

1 reference

25 July 2017

Liem TK

2

1 reference

25 July 2017

Spadone D

3

1 reference

25 July 2017

Nichols WK

4

1 reference

25 July 2017

Silver D

5

1 reference

25 July 2017

publication date

1 May 1999

1 reference

Journal of Vascular Surgery

25 July 2017

published in

1 reference

25 July 2017

volume

29

1 reference

25 July 2017

issue

5

1 reference

25 July 2017

page(s)

779-85; discussion 785-6

1 reference

Heparin-induced thrombocytopenia

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

Heparin-associated thrombocytopenia: a critical review and pooled analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

Heparin-induced thrombocytopenia: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

Heparin flushes and thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

Heparin-induced thrombocytopenia, thrombosis, and hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

The incidence of heparin-induced antibodies in patients undergoing vascular surgery: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

Heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

1 reference

7 January 2021

Hidden 19S IgM rheumatoid factors

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

A 14-year study of heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970203-X

7 January 2021

10.1016/S0741-5214(99)70203-X

Identifiers

DOI

1 reference

25 July 2017

1 reference